The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production

NCT03141827 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: Insulin
DRUG: Placebo

Sponsor

University Health Network, Toronto